139 related articles for article (PubMed ID: 14760740)
1. Construction of an artificial receptor protein ("anticalin") based on the human apolipoprotein D.
Vogt M; Skerra A
Chembiochem; 2004 Feb; 5(2):191-9. PubMed ID: 14760740
[TBL] [Abstract][Full Text] [Related]
2. Crystallographic analysis of an "anticalin" with tailored specificity for fluorescein reveals high structural plasticity of the lipocalin loop region.
Korndörfer IP; Beste G; Skerra A
Proteins; 2003 Oct; 53(1):121-9. PubMed ID: 12945055
[TBL] [Abstract][Full Text] [Related]
3. Alternative binding proteins: anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities.
Skerra A
FEBS J; 2008 Jun; 275(11):2677-83. PubMed ID: 18435758
[TBL] [Abstract][Full Text] [Related]
4. Combinatorial design of an Anticalin directed against the extra-domain b for the specific targeting of oncofetal fibronectin.
Gebauer M; Schiefner A; Matschiner G; Skerra A
J Mol Biol; 2013 Feb; 425(4):780-802. PubMed ID: 23238252
[TBL] [Abstract][Full Text] [Related]
5. A novel type of receptor protein, based on the lipocalin scaffold, with specificity for digoxigenin.
Schlehuber S; Beste G; Skerra A
J Mol Biol; 2000 Apr; 297(5):1105-20. PubMed ID: 10764576
[TBL] [Abstract][Full Text] [Related]
6. Engineered protein scaffolds for molecular recognition.
Skerra A
J Mol Recognit; 2000; 13(4):167-87. PubMed ID: 10931555
[TBL] [Abstract][Full Text] [Related]
7. Bacterially produced apolipoprotein D binds progesterone and arachidonic acid, but not bilirubin or E-3M2H.
Vogt M; Skerra A
J Mol Recognit; 2001; 14(1):79-86. PubMed ID: 11180564
[TBL] [Abstract][Full Text] [Related]
8. Construction of ribosome display library based on lipocalin scaffold and screening anticalins with specificity for estradiol.
Liu J; Ning B; Liu M; Sun Y; Sun Z; Zhang Y; Fan X; Zhou Z; Gao Z
Analyst; 2012 May; 137(10):2470-9. PubMed ID: 22489281
[TBL] [Abstract][Full Text] [Related]
9. Serendipitous fatty acid binding reveals the structural determinants for ligand recognition in apolipoprotein M.
Sevvana M; Ahnström J; Egerer-Sieber C; Lange HA; Dahlbäck B; Muller YA
J Mol Biol; 2009 Nov; 393(4):920-36. PubMed ID: 19733574
[TBL] [Abstract][Full Text] [Related]
10. Anticalins as alternative binding proteins for therapeutic use.
Skerra A
Curr Opin Mol Ther; 2007 Aug; 9(4):336-44. PubMed ID: 17694446
[TBL] [Abstract][Full Text] [Related]
11. Duocalins: engineered ligand-binding proteins with dual specificity derived from the lipocalin fold.
Schlehuber S; Skerra A
Biol Chem; 2001 Sep; 382(9):1335-42. PubMed ID: 11688717
[TBL] [Abstract][Full Text] [Related]
12. Rational engineering of a fluorescein-binding anticalin for improved ligand affinity.
Vopel S; Mühlbach H; Skerra A
Biol Chem; 2005 Nov; 386(11):1097-104. PubMed ID: 16307475
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization and developmental expression pattern of the chicken apolipoprotein D gene: implications for the evolution of vertebrate lipocalins.
Ganfornina MD; Sánchez D; Pagano A; Tonachini L; Descalzi-Cancedda F; Martínez S
Dev Dyn; 2005 Jan; 232(1):191-9. PubMed ID: 15580625
[TBL] [Abstract][Full Text] [Related]
14. Is apolipoprotein D a mammalian bilin-binding protein?
Peitsch MC; Boguski MS
New Biol; 1990 Feb; 2(2):197-206. PubMed ID: 2083249
[TBL] [Abstract][Full Text] [Related]
15. Anticalins: the lipocalin family as a novel protein scaffold for the development of next-generation immunotherapies.
Hohlbaum AM; Skerra A
Expert Rev Clin Immunol; 2007 Jul; 3(4):491-501. PubMed ID: 20477155
[TBL] [Abstract][Full Text] [Related]
16. The menagerie of human lipocalins: a natural protein scaffold for molecular recognition of physiological compounds.
Schiefner A; Skerra A
Acc Chem Res; 2015 Apr; 48(4):976-85. PubMed ID: 25756749
[TBL] [Abstract][Full Text] [Related]
17. Tuning ligand affinity, specificity, and folding stability of an engineered lipocalin variant -- a so-called 'anticalin' -- using a molecular random approach.
Schlehuber S; Skerra A
Biophys Chem; 2002 May; 96(2-3):213-28. PubMed ID: 12034442
[TBL] [Abstract][Full Text] [Related]
18. Anticalins: exploiting a non-Ig scaffold with hypervariable loops for the engineering of binding proteins.
Richter A; Eggenstein E; Skerra A
FEBS Lett; 2014 Jan; 588(2):213-8. PubMed ID: 24239535
[TBL] [Abstract][Full Text] [Related]
19. Engineering molecular recognition of endoxylanase enzymes and their inhibitors through phage display.
Beliën T; Van Campenhout S; Vanden Bosch A; Bourgois TM; Rombouts S; Robben J; Courtin CM; Delcour JA; Volckaert G
J Mol Recognit; 2007; 20(2):103-12. PubMed ID: 17393541
[TBL] [Abstract][Full Text] [Related]
20. Conformational and dynamics changes induced by bile acids binding to chicken liver bile acid binding protein.
Eberini I; Guerini Rocco A; Ientile AR; Baptista AM; Gianazza E; Tomaselli S; Molinari H; Ragona L
Proteins; 2008 Jun; 71(4):1889-98. PubMed ID: 18175325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
